Skip to results
Modify your search
NARROW
1-20 of 234
Subject: Clinical trials
Journal Article
Corticosteroid-sparing effects of risankizumab efficacy and safety in patients with moderately to severely active ulcerative colitis
Journal of Crohn's and Colitis, Volume 19, Issue 4, April 2025, jjaf025, https://doi.org/10.1093/ecco-jcc/jjaf025
Published: 01 April 2025
Journal Article
Patient–donor similarity and donor-derived species contribute to the outcome of fecal microbiota transplantation for ulcerative colitis Get access
Journal of Crohn's and Colitis, Volume 19, Issue 4, April 2025, jjaf054, https://doi.org/10.1093/ecco-jcc/jjaf054
Published: 01 April 2025
Journal Article
Novel outcomes in inflammatory bowel disease
Journal of Crohn's and Colitis, Volume 19, Issue 4, April 2025, jjaf040, https://doi.org/10.1093/ecco-jcc/jjaf040
Published: 13 March 2025
Journal Article
Janus kinase inhibitors in the management of acute severe ulcerative colitis: a comprehensive review Get access
Journal of Crohn's and Colitis, Volume 19, Issue 2, February 2025, jjaf021, https://doi.org/10.1093/ecco-jcc/jjaf021
Published: 31 January 2025
Journal Article
Assessment and reporting of extraintestinal manifestations and fatigue in phase 3 inflammatory bowel disease clinical trials Get access
Journal of Crohn's and Colitis, Volume 19, Issue 1, January 2025, jjaf009, https://doi.org/10.1093/ecco-jcc/jjaf009
Published: 18 January 2025
Journal Article
Improvement in serum eosinophilia is observed in clinical responders to ustekinumab but not adalimumab in inflammatory bowel disease
Journal of Crohn's and Colitis, Volume 19, Issue 1, January 2025, jjaf006, https://doi.org/10.1093/ecco-jcc/jjaf006
Published: 13 January 2025
Journal Article
Risankizumab efficacy and safety based on prior inadequate response or intolerance to advanced therapy: post hoc analysis of the INSPIRE and COMMAND phase 3 studies
Journal of Crohn's and Colitis, Volume 19, Issue 1, January 2025, jjaf005, https://doi.org/10.1093/ecco-jcc/jjaf005
Published: 13 January 2025
Journal Article
Open Label Vancomycin in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Improved Colonic Disease Activity and Associations With Changes in Host–Microbiome–Metabolomic Signatures
Journal of Crohn's and Colitis, Volume 19, Issue 2, February 2025, jjae189, https://doi.org/10.1093/ecco-jcc/jjae189
Published: 14 December 2024
Journal Article
Disparities in Gender and Race Representation Among Authors of Inflammatory Bowel Disease Clinical Trials Get access
Journal of Crohn's and Colitis, jjae184, https://doi.org/10.1093/ecco-jcc/jjae184
Published: 07 December 2024
Journal Article
Upadacitinib for Induction of Remission in Pediatric Ulcerative Colitis: An International Multicenter Study Get access
Journal of Crohn's and Colitis, jjae182, https://doi.org/10.1093/ecco-jcc/jjae182
Published: 28 November 2024
Journal Article
Low Incidence of Macular Edema and Other Ocular Events in the Etrasimod Development Program
Journal of Crohn's and Colitis, jjae173, https://doi.org/10.1093/ecco-jcc/jjae173
Published: 22 November 2024
Journal Article
Partial Enteral Nutrition in the Management of Crohn’s Disease: A Systematic Review and Meta-Analysis
Journal of Crohn's and Colitis, jjae177, https://doi.org/10.1093/ecco-jcc/jjae177
Published: 20 November 2024
Journal Article
Use of Modified Multiplier of the Simple Endoscopic Score for Crohn’s Disease Endoscopic Improvement Thresholds Enhances Effect Size Differentiation Between Adalimumab Versus Placebo: A Post Hoc Analysis of the EXTEND Trial
Journal of Crohn's and Colitis, Volume 19, Issue 4, April 2025, jjae171, https://doi.org/10.1093/ecco-jcc/jjae171
Published: 12 November 2024
Journal Article
Risankizumab Is Associated With Normalization of Biomarkers in Patients With Crohn’s Disease: Results From the Phase 3 ADVANCE, MOTIVATE, and FORTIFY Studies
Journal of Crohn's and Colitis, Volume 19, Issue 4, April 2025, jjae164, https://doi.org/10.1093/ecco-jcc/jjae164
Published: 01 November 2024
Journal Article
Effectiveness of Transitional Care in Inflammatory Bowel Disease; Development, Validation, and Initial Outcomes of a Transition Success Score
Journal of Crohn's and Colitis, Volume 19, Issue 4, April 2025, jjae166, https://doi.org/10.1093/ecco-jcc/jjae166
Published: 01 November 2024
Journal Article
The Bidirectional Effects of Periodontal Disease and Oral Dysbiosis on Gut Inflammation in Inflammatory Bowel Disease Get access
Journal of Crohn's and Colitis, Volume 19, Issue 4, April 2025, jjae162, https://doi.org/10.1093/ecco-jcc/jjae162
Published: 24 October 2024
Journal Article
Etrasimod Corticosteroid-Free Efficacy, Impact of Concomitant Corticosteroids on Efficacy and Safety, and Corticosteroid-Sparing Effect in Ulcerative Colitis: Analyses of the ELEVATE UC Clinical Program
Journal of Crohn's and Colitis, Volume 19, Issue 3, March 2025, jjae150, https://doi.org/10.1093/ecco-jcc/jjae150
Published: 22 September 2024
Journal Article
Outcomes of Patients With Prior Biologic Intolerance Are Better Than Those With Biologic Failure in Clinical Trials of Inflammatory Bowel Disease
Journal of Crohn's and Colitis, Volume 19, Issue 3, March 2025, jjae151, https://doi.org/10.1093/ecco-jcc/jjae151
Published: 20 September 2024
Journal Article
Dynamics of Gut Microbiota After Fecal Microbiota Transplantation in Ulcerative Colitis: Success Linked to Control of Prevotellaceae
Journal of Crohn's and Colitis, Volume 19, Issue 2, February 2025, jjae137, https://doi.org/10.1093/ecco-jcc/jjae137
Published: 03 September 2024
Journal Article
Achievement of Endoscopic Remission After Induction Reduces Hospitalization Burden in Crohn’s Disease: Findings From a Pooled Post Hoc Analysis of Risankizumab and Upadacitinib Phase III Trials
Journal of Crohn's and Colitis, Volume 19, Issue 2, February 2025, jjae128, https://doi.org/10.1093/ecco-jcc/jjae128
Published: 30 August 2024
